Suppr超能文献

一种新的双等位基因突变导致两兄弟 SAVI。

A Novel Biallelic Gene Variant Causing SAVI in Two Siblings.

机构信息

Department of Pediatrics, Medical Genetic Division, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Front Immunol. 2021 Jan 8;11:599564. doi: 10.3389/fimmu.2020.599564. eCollection 2020.

Abstract

STING-associated vasculopathy of infantile-onset (SAVI) is one of the newly identified types of interferonopathies. SAVI is caused by heterozygous gain-of-function mutations in the . We herein report for the first time a homozygous variant in the in two siblings that resulted in constitutive activation of gene and the SAVI phenotype. Exome sequencing revealed a novel homozygous NM_198282.3: c.841C>T; p.(Arg281Trp) variant in exon 7 of the gene. The variant segregated in the family to be homozygous in all affected and either heterozygous or wild type in all healthy. Computational structural analysis of the mutants revealed changes in the STING protein structure/function. Elevated serum beta-interferon levels were observed in the patients compared to the control family members. Treatment with Janus kinase inhibitor (JAK-I) Ruxolitinib suppressed the inflammatory process, decreased beta-interferon levels, and stopped the progression of the disease.

摘要

婴儿发作的 STING 相关血管病(SAVI)是新确定的干扰素病类型之一。SAVI是由. 中的杂合获得性功能突变引起的。我们在此首次报道了两个同胞中. 中的纯合变异,导致 基因的组成性激活和 SAVI 表型。外显子组测序显示. 基因外显子 7 中的一个新的纯合性 NM_198282.3: c.841C>T; p.(Arg281Trp) 变异。该变异在家族中与所有受影响的个体纯合,而在所有健康的个体中为杂合或野生型。对突变体的计算结构分析表明,STING 蛋白结构/功能发生了变化。与对照组家庭成员相比,患者的血清β干扰素水平升高。用 Janus 激酶抑制剂(JAK-I)芦可替尼治疗抑制了炎症过程,降低了β干扰素水平,并阻止了疾病的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bcd/7820697/4b0c375577c5/fimmu-11-599564-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验